Side-by-side comparison of AI visibility scores, market position, and capabilities
Memphis corrugated packaging and containerboard (NYSE: IP) ~$23B combined revenue; DS Smith $7.2B acquisition creates 65,000+ employee global packaging leader with $514M+ synergies competing with Smurfit WestRock.
International Paper Company is a Memphis, Tennessee-based global packaging and pulp company — publicly traded on the New York Stock Exchange (NYSE: IP) as an S&P 500 Materials component — manufacturing corrugated packaging, containerboard, and fiber-based packaging solutions for industrial and consumer goods companies through approximately 65,000 employees in 30+ countries following the completion of its $7.2 billion acquisition of DS Smith plc (UK-listed packaging company) in 2024. The DS Smith acquisition — completed through an all-share transaction in which legacy International Paper shareholders own 65.9% and former DS Smith shareholders own 34.1% of the combined company — creates a global sustainable packaging leader with combined capacity to serve customer supply chains from North America to Europe to emerging markets, with expected synergies of at least $514 million from manufacturing network optimization, procurement consolidation, and shared commercial capabilities. CEO Andy Silvernail leads the combined company's integration. International Paper's portfolio is primarily containerboard (the linerboard and medium used to manufacture corrugated shipping boxes) and corrugated packaging — the industry's largest-volume product, required by every e-commerce, retail, food and beverage, and industrial goods company to ship and protect products through supply chains. DS Smith's complementary European containerboard and corrugated operations provide geographic diversification and serve European CPG, e-commerce, and manufacturing customers that could not be reached efficiently from IP's North American manufacturing network.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.